Neoadjuvant Therapy for Locally Advanced or Oligometastatic Prostate Cancer: a Retrospective Comparative Single-Center Study
Author:
Funder
the Zhejiang Provincial Foundation for Medical and Health Sciences
Publisher
Springer Science and Business Media LLC
Subject
Surgery
Link
https://link.springer.com/content/pdf/10.1007/s12262-022-03401-8.pdf
Reference13 articles.
1. Williams SB, Davis JW, Wang X, Achim MF, Zurita-Saavedra A, Matin SF et al (2016) Neoadjuvant systemic therapy before radical prostatectomy in high-risk prostate cancer does not increase surgical morbidity: contemporary results using the Clavien system. Clin Genitourin Cancer 14:130–138
2. Battaglia A, De Meerleer G, Tosco L, Moris L, Van den Broeck T, Devos G et al (2019) Novel insights into the management of oligometastatic prostate cancer: a comprehensive review. Eur Urol Oncol 2:174–188
3. Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M et al (2021) EAU-EANM-ESTRO-ESUR-SIOG Guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer. Eur Urol 79:263–282
4. Berglund RK, Tangen CM, Powell IJ, Lowe BA, Haas GP, Carroll PR et al (2012) Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109. Urology 79:633–637
5. Pan J, Chi C, Qian H, Zhu Y, Shao X, Sha J et al (2019) Neoadjuvant chemohormonal therapy combined with radical prostatectomy and extended PLND for very high risk locally advanced prostate cancer: a retrospective comparative study. Urol Oncol 37:991–998
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3